arrow
T

Takayuki Hashimoto

hokkaido university
H指数:34
被引数:3,525

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study

局部晚期非小细胞肺癌放疗中心脏和肺部剂量参数的最佳组合:一项多中心回顾性研究

2026-07-010
PRE
Japanese prospective registry study of particle therapy for esophageal cancer including comparison with clinical trials in Japan

日本食管癌粒子疗法前瞻性注册研究,包括与日本临床试验的比较

2026-07-010
PRE
Response to “Reconsidering ‘photon-ineligible’ status in concurrent chemo-proton therapy for stage III non-small cell lung cancer”

对“重新考虑局部晚期非小细胞肺癌同期化质子治疗中‘光子不适格’状态的”的回应

2026-06-240
PRE
Proton beam therapy for patients with distal cholangiocarcinoma: a multicenter prospective registry study (Influence of age factor)

质子束疗法治疗远端胆管癌患者:一项多中心前瞻性登记研究(年龄因素的影响)

2026-05-010
PRE
Endocrine disorders in pediatric medulloblastoma survivors treated with X-ray or proton beam therapy: a single-institution retrospective study

儿科髓母细胞瘤幸存者中接受X射线或质子束治疗后的内分泌紊乱:一项单机构回顾性研究

2026-04-010
PRE
Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact

前瞻性登记和荟萃分析:粒子治疗肝细胞癌的临床结果与真实世界影响

2026-02-200
OAAI
Proton beam therapy for intrahepatic and perihilar cholangiocarcinoma: a multicenter prospective registry study

质子束疗法治疗肝内和肝门部胆管癌:一项多中心前瞻性登记研究

2025-12-040
PRE
Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry study

不可切除的III期非小细胞肺癌同期化疗联合质子疗法的长期疗效:一项日本国家登记研究

2025-11-260
OAAI
A Precise Reirradiation Supporting Tool Initiative (PRISTIN) for Prescribing Absorbed Dose and Number of Fractions in Reirradiation

精确再放疗支持工具倡议(PRISTIN)——用于规定再放疗中的吸收剂量和分割次数

2025-10-010
OAAI
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry

可手术的早期肺癌的质子和碳离子放射治疗; 前瞻性的全国注册

2024-09-010
PRE
Particle Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study, Systematic Review and Meta-Analysis
2024-08-280
OAAI
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study
2023-02-072
OAAI